NeurosciencebioRxivPreprint
Identification of Fibrinogen as a Plasma Protein Binding Partner for Lecanemab Biosimilar IgG: Implications for Alzheimer's Disease Therapy
Jean‐Pierre Bellier, Andrea M. Román Viera, Caitlyn Christiano…·Lei Liu
This study identifies fibrinogen as a plasma protein binding partner for lecanemab biosimilar, suggesting it may affect drug half-life and free antibody levels in Alzheimer's disease therapy.
1 citation